Chemosaturation of the Liver - an Update

被引：0
作者：
Ebel, Sebastian [1 ]
Struck, Manuel Florian [2 ]
van Boemmel, Florian [3 ]
Beeskow, Anne Bettina [1 ]
Goessmann, Holger [1 ]
Denecke, Timm [1 ]
机构：
[1] Univ Leipzig, Klin & Poliklin Diagnost & Intervent Radiol, Liebigstr 20, D-04103 Leipzig, Germany
[2] Univ Leipzig, Klin & Poliklin Anasthesiol & Intensivtherapie, Leipzig, Germany
[3] Univ Leipzig, Sekt Hepatol, Klin Innere Med 2, Leipzig, Germany
来源：
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 2023年 / 195卷 / 01期
关键词：
abdomen; hematologic; angiography; interventional procedures; PERCUTANEOUS HEPATIC PERFUSION; UVEAL MELANOMA; OCULAR MELANOMA; METASTATIC MELANOMA; TREATMENT OPTIONS; SURVIVAL; CHOLANGIOCARCINOMA; CHEMOEMBOLIZATION; MELPHALAN; SAFETY;
D O I：
10.1055/a-1858-3418
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Background Percutaneous hepatic perfusion (CS-PHP) is a treatment option for primary and secondary liver neoplasms and subject of intensive research. This present article provides an overview of CS-PHP regarding patient safety, feasibility and effectiveness based on recent studies. Method We performed a PubMed search including the search terms chemosaturation, hepatic chemosaturation, percutaneous perfusion and melphalan. Results and conclusion CS-PHP is a promising procedure for the treatment of uveal melanoma and cholangiocellular carcinoma. There are insufficient data regarding the effectiveness of CS-PHP with respect to other tumor entities. Since CS-PHP can be accompanied by multiple transient side effects and complications, close interdisciplinary cooperation is necessary.
引用
收藏
页码：30 / 37
页数：8
相关论文
共 44 条
  • [1] Response, Survival, and Prognostic Factors After Hepatic Arterial Chemoembolization in Patients With Liver Metastases From Cutaneous Melanoma
    Ahrar, Judy
    Gupta, Sanjay
    Ensor, Joe
    Ahrar, Kamran
    Madoff, David C.
    Wallace, Michael J.
    Murthy, Ravi
    Tam, Alda
    Hwu, Patrick
    Bedikian, Agop Y.
    [J]. CANCER INVESTIGATION, 2011, 29 (01) : 49 - 55
  • [2] Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
    Akateh, Clifford
    Ejaz, Aslam M.
    Pawlik, Timothy Michael
    Cloyd, Jordan M.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (10) : 693 - 708
  • [3] Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience
    Artzner, Christoph
    Mossakowski, Oliver
    Hefferman, Gerald
    Grosse, Ulrich
    Hoffmann, Ruediger
    Forschner, Andrea
    Eigentler, Thomas
    Syha, Roland
    Groezinger, Gerd
    [J]. CANCER IMAGING, 2019, 19 (1):
  • [4] Hepatobiliary Cancers, Version 2.2021
    Benson III, Al B.
    D'Angelica, Michael I.
    Abbott, Daniel E.
    Anaya, Daniel A.
    Anders, Robert
    Are, Chandrakanth
    Bachini, Melinda
    Borad, Mitesh
    Brown, Daniel
    Burgoyne, Adam
    Chahal, Prabhleen
    Chang, Daniel T.
    Cloyd, Jordan
    Covey, Anne M.
    Glazer, Evan S.
    Goyal, Lipika
    Hawkins, William G.
    Iyer, Renuka
    Jacob, Rojymon
    Kelley, R. Kate
    Kim, Robin
    Levine, Matthew
    Palta, Manisha
    Park, James O.
    Raman, Steven
    Reddy, Sanjay
    Sahai, Vaibhav
    Schefter, Tracey
    Singh, Gagandeep
    Stein, Stacey
    Vauthey, Jean-Nicolas
    Venook, Alan P.
    Yopp, Adam
    McMillian, Nicole R.
    Hochstetler, Cindy
    Darlow, Susan D.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (05): : 541 - 565
  • [5] Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
    Bridgewater, John
    Galle, Peter R.
    Khan, Shahid A.
    Llovet, Josep M.
    Park, Joong-Won
    Patel, Tushar
    Pawlik, Timothy M.
    Gores, Gregory J.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (06) : 1268 - 1289
  • [6] Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan-Long-Term Overall Survival Negatively Correlates with Tumor Burden
    Bruening, R.
    Tiede, M.
    Schneider, M.
    Wohlmuth, P.
    Weilert, H.
    Oldhafer, K.
    Stang, A.
    [J]. RADIOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [7] Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases
    Carr, Michael J.
    Sun, James
    Cohen, Jonathan B.
    Liu, Jinhong
    Serdiuk, Andrew A.
    Stewart, Stephen R.
    Doobay, Navin
    Duclos, Andrew
    Seal, David A.
    Choi, Junsung
    Zager, Jonathan S.
    [J]. CANCER CONTROL, 2020, 27 (01)
  • [8] Metastatic disease from uveal melanoma: treatment options and future prospects
    Carvajal, Richard D.
    Schwartz, Gary K.
    Tezel, Tongalp
    Marr, Brian
    Francis, Jasmine H.
    Nathan, Paul D.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (01) : 38 - 44
  • [9] Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
    de Leede, Eleonora M.
    Burgmans, Mark C.
    Meijer, T. Susanna
    Martini, Christian H.
    Tijl, Fred G. J.
    Vuyk, Jaap
    van Erkel, Arian R.
    van der Velde, Cornelis J. H.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (08) : 1196 - 1205
  • [10] Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery
    Dewald, C. L. A.
    Becker, L. S.
    Maschke, S. K.
    Meine, T. C.
    Alten, T. A.
    Kirstein, M. M.
    Vogel, A.
    Wacker, F. K.
    Meyer, B. C.
    Hinrichs, J. B.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2020, 37 (06) : 683 - 692
12345